Medrad<sup>®</sup> Mark 7 Arterion Injection System

A Natural Choice of CV Injector

Medrad<sup>®</sup> Mark 7 Arterion logo

Woman using the Medrad<sup>®</sup> Mark 7 Arterion injector

Versatility

Your Versatile Interventional Radiology Injector

With use across a range of IR procedures,1-4 automated or manual delivery of contrast, connectivity to imaging equipment, and a range of mounting options.

Find Out More

Control

Confidence with Control

With precision control of fluid delivery, you can confidently focus during your procedure.

Find Out More
Medrad<sup>®</sup> Mark 7 Arterion injector
Medrad<sup>®</sup> Mark 7 Arterion injector close up

Interoperability

Working With You

Versatile disposables, flexible configurations and connectivity with imaging equipment help to enhance workflow efficiencies.

Find Out More

Trust

Expertise You Can Rely On

Bayer is a pioneering leader in the field of angiography with over 50 years experience in the field of power injection and contrast media.

Find Out More
Medrad<sup>®</sup> Mark 7 Arterion injector

Product Details

More About Arterion

Your Natural Choice for Interventional Radiology

Your Natural Choice for Interventional Radiology

Download PDF
Ultravist<sup>®</sup> preview

Ultravist®

Clear Direction.
Confidence with Ultravist®

Find Out More

Talk to Our Team

To learn more about Arterion or other Bayer Radiology solutions please contact:

Contact Bayer
One icon with people shaking hands, Arterion injector icon

References

  • 1. Mascoli C, et al. Indelicato G, Gargiulo M, Stella A. Standardization of a Carbon Dioxide Automated System for Endovascular Aortic Aneurysm Repair. Ann Vasc Surg. 2018 ;51:160-169. Return to content
  • 2. Ognard J, et al. A new time-resolved 3D angiographic technique (4D DSA): Description, and assessment of its reliability in Spetzler-Martin grading of cerebral arteriovenous malformations. J Neuroradiol. 2018;45(3):177-185. Return to content
  • 3. Nijssen EC, et al. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial. Lancet. 2017 1;389(10076):1312-1322. Return to content
  • 4. Mascoli C, Faggioli G, Gallitto E, Vento V, Indelicato G, Pini R, Vacirca A, Stella A, Gargiulo M. The Assessment of Carbon Dioxide Automated Angiography in Type II Endoleaks Detection: Comparison with Contrast-Enhanced Ultrasound. Contrast Media Mol Imaging. 2018 Mar 26;2018:7647165. doi: 10.1155/2018/7647165. PMID: 29780288; PMCID: PMC5892285. Return to content